Dr. Georges is the current holder of the Canadian Pacific Chair in Biotechnology of McGill University. He also served for several years as the Graduate Program Director of the Biotechnology programs, for which he is the acting director this fall 2016. His research focuses on drug resistance mechanisms in malaria, cancer drug resistance and protein interactions. He has authored more than 100 peer-reviewed publications, book chapters and patents. He is the Associate Editor-in Chief of International Journal of Biochemistry and Molecular Biology. In 1998, he co-founded Aurelium BioPharma Inc. (McGill Spin-off biotechnology company).